Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

iX Biopharma Signs Exclusive License Agreement For Wafermine And Other Sublingual Ketamine Wafer Products

prnasiaNovember 25, 2021

Tag: iX Biopharma , Wafermine , Ketamine

PharmaSources Customer Service